AJP - Endo Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Endocrinol Metab 283: E980-E987, 2002. First published July 30, 2002; doi:10.1152/ajpendo.00196.2002
0193-1849/02 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
283/5/E980    most recent
00196.2002v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (12)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cettour-Rose, P.
Right arrow Articles by Rohner-Jeanrenaud, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cettour-Rose, P.
Right arrow Articles by Rohner-Jeanrenaud, F.
Vol. 283, Issue 5, E980-E987, November 2002

Central stimulatory effect of leptin on T3 production is mediated by brown adipose tissue type II deiodinase

Philippe Cettour-Rose1, Albert G. Burger1, Christoph A. Meier1, Theo J. Visser2, and Françoise Rohner-Jeanrenaud1

1 Division of Endocrinology and Diabetology, Department of Medicine, Faculty of Medicine, University of Geneva, 1211 Geneva 14, Switzerland; and 2 Internal Medicine III, Erasmus University, 3015 GD, Rotterdam, The Netherlands

To assess whether intracerebroventricular leptin administration affects monodeiodinase type II (D2) activity in the tissues where it is expressed [cerebral cortex, hypothalamus, pituitary, and brown adipose tissue (BAT)], hepatic monodeiodinase type I (D1) activity was inhibited with propylthiouracil (PTU), and small doses of thyroxine (T4; 0.6 nmol · 100 g body wt-1 · day-1) were supplemented to compensate for the PTU-induced hypothyroidism. Two groups of rats were infused with leptin for 6 days, one of them being additionally treated with reverse triiodothyronine (rT3), an inhibitor of D2. Control rats were infused with vehicle and pair-fed the amount of food consumed by leptin-infused animals. Central leptin administration produced marked increases in D2 mRNA expression and activity in BAT, changes that were likely responsible for increased plasma T3 and decreased plasma T4 levels. Indeed, plasma T3 and T4 concentrations were unaltered by central leptin administration in the presence of rT3. The additional observation of a leptin-induced increased mRNA expression of BAT uncoupling protein-1 suggested that the effect on BAT D2 may be mediated by the sympathetic nervous system.

intracerebroventricular leptin; triiodothyronine; thyroid hormones


This article has been cited by other articles:


Home page
 J EndocrinolHome page
S C P Dutra, E G Moura, A L Rodrigues, P C Lisboa, I Bonomo, F P Toste, and M C F Passos
Cold exposure restores the decrease in leptin receptors (OB-Rb) caused by neonatal leptin treatment in 30-day-old rats
J. Endocrinol., November 1, 2007; 195(2): 351 - 358.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
P. C. Lisboa, K. J. Oliveira, A. Cabanelas, T. M. Ortiga-Carvalho, and C. C. Pazos-Moura
Acute cold exposure, leptin, and somatostatin analog (octreotide) modulate thyroid 5'-deiodinase activity
Am J Physiol Endocrinol Metab, June 1, 2003; 284(6): E1172 - E1176.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online